Court lowers penalty against J&J subsidiary

Columbia, S.C. • South Carolina’s highest court on Wednesday further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive marketing of an anti-psychotic drug. In its ruling, the state Supreme Court ordered Janssen Pharmaceutica, Inc., to pay about $124 million — more than $200 million less than the original penalty amount. In 2011, a trial court ordered the drug maker to pay $327 million, saying Janssen broke the law by downplaying to doctors the links between diabetes...

Share this post